APPLICATION
ANDA220119
TYPE
ANDA
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
None (Tentative Approval)
Products
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA,LEVODOPA 48.75MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA,LEVODOPA 245MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA,LEVODOPA 23.75MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA,LEVODOPA 195MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA,LEVODOPA 61.25MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA,LEVODOPA 95MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA,LEVODOPA 145MG · CAPSULE, EXTENDED RELEASE
Approval history
2025-12-04UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.